Krystal Biotech (KRYS) Total Non-Current Liabilities (2018 - 2026)
Krystal Biotech (KRYS) reported Total Non-Current Liabilities of $148.92 million for Q3 2026, up 50.3% from $99.08 million a year earlier and up 10.8% from the prior quarter.
Powered by 
Analysis
Krystal Biotech (KRYS) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends
At the end of FY2025, Krystal Biotech posted Total Non-Current Liabilities of $110.51 million, up 2.3% from FY2024.
- By year, Total Non-Current Liabilities came in at $108.04 million in FY2024 (+172.0%) and $39.71 million in FY2023.
- The Q3 2026 figure ranks as the highest quarterly Total Non-Current Liabilities in data going back to Q3 2018.
- Year over year, Total Non-Current Liabilities has now increased in each of the last six quarters, with growth averaging 46.1% over the last seven quarters.
- Per Business Quant data, the three quarters before Q3 2026 came in at $134.44 million (Q2 2026), $115.11 million (Q1 2026) and $110.51 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 60.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 102.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 117.60 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 79.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -36.84 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 76.12 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 36.05 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 96.04 Bn |
| 10 | Krystal Biotech | 9.08 Bn | 5.67 Bn | 119.79 Mn | 148.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 148.92 Mn |
| Jun 30, 2026 | 134.44 Mn |
| Mar 31, 2026 | 115.11 Mn |
| Dec 31, 2025 | 110.51 Mn |
| Sep 30, 2025 | 99.08 Mn |
| Jun 30, 2025 | 94.95 Mn |
| Mar 31, 2025 | 87.74 Mn |
| Dec 31, 2024 | 108.04 Mn |
| Sep 30, 2024 | 95.71 Mn |
| Jun 30, 2024 | 78.18 Mn |
| Dec 31, 2023 | 39.71 Mn |
| Dec 31, 2018 | 2.60 Mn |
| Sep 30, 2018 | 1.92 Mn |
API Access
Krystal Biotech Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=KRYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "KRYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=KRYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();